• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses

tetano

Editor, Senior Moderator
Open Forum Infect Dis. 2015 Apr 15;2(2):ofv052. doi: 10.1093/ofid/ofv052. eCollection 2015.
[h=1]Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.[/h] Reber AJ[SUP]1[/SUP], Kim JH[SUP]1[/SUP], Biber R[SUP]1[/SUP], Talbot HK[SUP]2[/SUP], Coleman LA[SUP]3[/SUP], Chirkova T[SUP]1[/SUP], Gross FL[SUP]1[/SUP], Steward-Clark E[SUP]1[/SUP], Cao W[SUP]1[/SUP], Jefferson S[SUP]1[/SUP], Veguilla V[SUP]1[/SUP], Gillis E[SUP]1[/SUP], Meece J[SUP]3[/SUP], Bai Y[SUP]1[/SUP], Tatum H[SUP]1[/SUP], Hancock K[SUP]1[/SUP], Stevens J[SUP]1[/SUP], Spencer S[SUP]1[/SUP], Chen J[SUP]1[/SUP], Gargiullo P[SUP]1[/SUP], Braun E[SUP]1[/SUP], Griffin MR[SUP]4[/SUP], Sundaram M[SUP]3[/SUP], Belongia EA[SUP]3[/SUP], Shay DK[SUP]1[/SUP], Katz JM[SUP]1[/SUP], Sambhara S[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Background.  Influenza disproportionately impacts older adults while current vaccines have reduced effectiveness in the older population. Methods.  We conducted a comprehensive evaluation of cellular and humoral immune responses of adults aged 50 years and older to the 2008-2009 seasonal trivalent inactivated influenza vaccine and assessed factors influencing vaccine response. Results.  Vaccination increased hemagglutination inhibition and neutralizing antibody; however, 66.3% of subjects did not reach hemagglutination inhibition titers ≥ 40 for H1N1, compared with 22.5% for H3N2. Increasing age had a minor negative impact on antibody responses, whereas prevaccination titers were the best predictors of postvaccination antibody levels. Preexisting memory B cells declined with age, especially for H3N2. However, older adults still demonstrated a significant increase in antigen-specific IgG(+) and IgA(+) memory B cells postvaccination. Despite reduced frequency of preexisting memory B cells associated with advanced age, fold-rise in memory B cell frequency in subjects 60+ was comparable to subjects age 50-59. Conclusions.  Older adults mounted statistically significant humoral and cell-mediated immune responses, but many failed to reach hemagglutination inhibition titers ≥40, especially for H1N1. Although age had a modest negative effect on vaccine responses, prevaccination titers were the best predictor of postvaccination antibody levels, irrespective of age.


[h=4]KEYWORDS:[/h] aging; immune response; influenza; older adults; vaccine

PMID: 26380344 [PubMed]
 
Back
Top Bottom